nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Vincristine—sarcoma	0.216	0.281	CbGbCtD
Tenofovir—ABCC10—Etoposide—sarcoma	0.198	0.257	CbGbCtD
Tenofovir—ABCC10—Doxorubicin—sarcoma	0.135	0.175	CbGbCtD
Tenofovir—ABCC2—Vincristine—sarcoma	0.0618	0.0802	CbGbCtD
Tenofovir—ABCC2—Etoposide—sarcoma	0.0566	0.0735	CbGbCtD
Tenofovir—CYP1A2—Dacarbazine—sarcoma	0.0432	0.056	CbGbCtD
Tenofovir—ABCC2—Doxorubicin—sarcoma	0.0386	0.0501	CbGbCtD
Tenofovir—CYP1A2—Etoposide—sarcoma	0.0211	0.0274	CbGbCtD
Tenofovir—AK2—mammary gland—sarcoma	0.00588	0.0591	CbGeAlD
Tenofovir—NME1-NME2—hematopoietic system—sarcoma	0.00473	0.0475	CbGeAlD
Tenofovir—Adenosine monophosphate—CREB1—sarcoma	0.0046	0.712	CrCbGaD
Tenofovir—AK4—mammary gland—sarcoma	0.00435	0.0437	CbGeAlD
Tenofovir—AK2—myometrium—sarcoma	0.00417	0.0419	CbGeAlD
Tenofovir—AK4—myometrium—sarcoma	0.00309	0.031	CbGeAlD
Tenofovir—NME2—embryo—sarcoma	0.0029	0.0291	CbGeAlD
Tenofovir—AK4—seminal vesicle—sarcoma	0.00279	0.028	CbGeAlD
Tenofovir—NME1—hematopoietic system—sarcoma	0.00275	0.0276	CbGeAlD
Tenofovir—AK2—uterus—sarcoma	0.00271	0.0272	CbGeAlD
Tenofovir—NME1—connective tissue—sarcoma	0.00265	0.0266	CbGeAlD
Tenofovir—NME2—hematopoietic system—sarcoma	0.00259	0.026	CbGeAlD
Tenofovir—NME1-NME2—liver—sarcoma	0.00245	0.0246	CbGeAlD
Tenofovir—NME1—skin of body—sarcoma	0.00239	0.024	CbGeAlD
Tenofovir—AK2—tendon—sarcoma	0.00237	0.0238	CbGeAlD
Tenofovir—AK2—bone marrow—sarcoma	0.0023	0.0231	CbGeAlD
Tenofovir—NME1—uterus—sarcoma	0.00208	0.0209	CbGeAlD
Tenofovir—AK4—cardiac atrium—sarcoma	0.00201	0.0202	CbGeAlD
Tenofovir—AK4—uterus—sarcoma	0.002	0.0201	CbGeAlD
Tenofovir—AK2—testis—sarcoma	0.00196	0.0197	CbGeAlD
Tenofovir—NME1—lymphoid tissue—sarcoma	0.00194	0.0194	CbGeAlD
Tenofovir—NME1-NME2—lymph node—sarcoma	0.00188	0.0189	CbGeAlD
Tenofovir—Adenosine monophosphate—SRC—sarcoma	0.00186	0.288	CrCbGaD
Tenofovir—AK2—liver—sarcoma	0.00186	0.0186	CbGeAlD
Tenofovir—NME2—lymphoid tissue—sarcoma	0.00182	0.0183	CbGeAlD
Tenofovir—NME1—bone marrow—sarcoma	0.00176	0.0177	CbGeAlD
Tenofovir—AK4—tendon—sarcoma	0.00175	0.0176	CbGeAlD
Tenofovir—NME1—testis—sarcoma	0.00151	0.0151	CbGeAlD
Tenofovir—ABCC10—myometrium—sarcoma	0.00146	0.0147	CbGeAlD
Tenofovir—AK4—testis—sarcoma	0.00145	0.0146	CbGeAlD
Tenofovir—NME1—liver—sarcoma	0.00143	0.0143	CbGeAlD
Tenofovir—AK2—lymph node—sarcoma	0.00142	0.0143	CbGeAlD
Tenofovir—NME2—testis—sarcoma	0.00142	0.0143	CbGeAlD
Tenofovir—AK4—liver—sarcoma	0.00137	0.0138	CbGeAlD
Tenofovir—NME2—liver—sarcoma	0.00134	0.0135	CbGeAlD
Tenofovir—ABCC10—seminal vesicle—sarcoma	0.00132	0.0133	CbGeAlD
Tenofovir—ABCC10—hematopoietic system—sarcoma	0.00126	0.0126	CbGeAlD
Tenofovir—NME1—lymph node—sarcoma	0.00109	0.011	CbGeAlD
Tenofovir—AK4—lymph node—sarcoma	0.00105	0.0106	CbGeAlD
Tenofovir—ABCC4—hematopoietic system—sarcoma	0.00104	0.0105	CbGeAlD
Tenofovir—SLC22A8—hematopoietic system—sarcoma	0.00104	0.0104	CbGeAlD
Tenofovir—NME2—lymph node—sarcoma	0.00103	0.0103	CbGeAlD
Tenofovir—ABCC10—cardiac atrium—sarcoma	0.000955	0.00959	CbGeAlD
Tenofovir—ABCC10—uterus—sarcoma	0.00095	0.00954	CbGeAlD
Tenofovir—ABCC10—lymphoid tissue—sarcoma	0.000886	0.00889	CbGeAlD
Tenofovir—ABCC10—tendon—sarcoma	0.000832	0.00836	CbGeAlD
Tenofovir—ABCC10—bone marrow—sarcoma	0.000806	0.00809	CbGeAlD
Tenofovir—ABCC4—uterus—sarcoma	0.000788	0.00791	CbGeAlD
Tenofovir—CYP1A2—hematopoietic system—sarcoma	0.000709	0.00712	CbGeAlD
Tenofovir—ABCC4—tendon—sarcoma	0.000691	0.00693	CbGeAlD
Tenofovir—ABCC10—testis—sarcoma	0.000689	0.00692	CbGeAlD
Tenofovir—ABCC4—bone marrow—sarcoma	0.000669	0.00671	CbGeAlD
Tenofovir—ABCC2—tendon—sarcoma	0.000668	0.00671	CbGeAlD
Tenofovir—ABCC10—liver—sarcoma	0.000652	0.00654	CbGeAlD
Tenofovir—ABCC4—testis—sarcoma	0.000572	0.00574	CbGeAlD
Tenofovir—Urethral disorder—Vincristine—sarcoma	0.00057	0.00465	CcSEcCtD
Tenofovir—Hepatitis—Mitoxantrone—sarcoma	0.000567	0.00461	CcSEcCtD
Tenofovir—ABCC2—testis—sarcoma	0.000553	0.00556	CbGeAlD
Tenofovir—Creatinine increased—Epirubicin—sarcoma	0.000553	0.0045	CcSEcCtD
Tenofovir—Back pain—Thiotepa—sarcoma	0.000553	0.0045	CcSEcCtD
Tenofovir—Bone pain—Epirubicin—sarcoma	0.000549	0.00447	CcSEcCtD
Tenofovir—ABCC4—liver—sarcoma	0.000541	0.00543	CbGeAlD
Tenofovir—Pneumonia—Etoposide—sarcoma	0.000528	0.0043	CcSEcCtD
Tenofovir—Infestation NOS—Etoposide—sarcoma	0.000525	0.00428	CcSEcCtD
Tenofovir—Infestation—Etoposide—sarcoma	0.000525	0.00428	CcSEcCtD
Tenofovir—Mediastinal disorder—Vincristine—sarcoma	0.000524	0.00427	CcSEcCtD
Tenofovir—ABCC2—liver—sarcoma	0.000523	0.00525	CbGeAlD
Tenofovir—Renal failure—Etoposide—sarcoma	0.000516	0.0042	CcSEcCtD
Tenofovir—Neuropathy peripheral—Etoposide—sarcoma	0.000515	0.00419	CcSEcCtD
Tenofovir—Creatinine increased—Doxorubicin—sarcoma	0.000511	0.00417	CcSEcCtD
Tenofovir—Mental disorder—Vincristine—sarcoma	0.00051	0.00415	CcSEcCtD
Tenofovir—Bone pain—Doxorubicin—sarcoma	0.000508	0.00414	CcSEcCtD
Tenofovir—ABCC10—lymph node—sarcoma	0.0005	0.00502	CbGeAlD
Tenofovir—Hepatobiliary disease—Etoposide—sarcoma	0.000497	0.00404	CcSEcCtD
Tenofovir—Back pain—Vincristine—sarcoma	0.00049	0.00399	CcSEcCtD
Tenofovir—Myalgia—Thiotepa—sarcoma	0.000486	0.00396	CcSEcCtD
Tenofovir—Arthralgia—Thiotepa—sarcoma	0.000486	0.00396	CcSEcCtD
Tenofovir—Anxiety—Thiotepa—sarcoma	0.000485	0.00395	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000483	0.00393	CcSEcCtD
Tenofovir—Myalgia—Dactinomycin—sarcoma	0.000483	0.00393	CcSEcCtD
Tenofovir—Back pain—Mitoxantrone—sarcoma	0.000477	0.00389	CcSEcCtD
Tenofovir—Urinary tract disorder—Etoposide—sarcoma	0.000465	0.00379	CcSEcCtD
Tenofovir—Urethral disorder—Etoposide—sarcoma	0.000462	0.00376	CcSEcCtD
Tenofovir—Nervous system disorder—Thiotepa—sarcoma	0.000457	0.00372	CcSEcCtD
Tenofovir—Skin disorder—Thiotepa—sarcoma	0.000453	0.00369	CcSEcCtD
Tenofovir—Anorexia—Thiotepa—sarcoma	0.000444	0.00362	CcSEcCtD
Tenofovir—Anorexia—Dactinomycin—sarcoma	0.000441	0.00359	CcSEcCtD
Tenofovir—Myalgia—Vincristine—sarcoma	0.000431	0.00351	CcSEcCtD
Tenofovir—Immune system disorder—Etoposide—sarcoma	0.000426	0.00347	CcSEcCtD
Tenofovir—Mediastinal disorder—Etoposide—sarcoma	0.000425	0.00346	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000425	0.00346	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000422	0.00343	CcSEcCtD
Tenofovir—Myalgia—Mitoxantrone—sarcoma	0.00042	0.00342	CcSEcCtD
Tenofovir—Arthralgia—Mitoxantrone—sarcoma	0.00042	0.00342	CcSEcCtD
Tenofovir—Chest pain—Mitoxantrone—sarcoma	0.00042	0.00342	CcSEcCtD
Tenofovir—Anxiety—Mitoxantrone—sarcoma	0.000418	0.00341	CcSEcCtD
Tenofovir—ABCC4—lymph node—sarcoma	0.000414	0.00416	CbGeAlD
Tenofovir—Renal failure acute—Epirubicin—sarcoma	0.000414	0.00337	CcSEcCtD
Tenofovir—Dyspepsia—Thiotepa—sarcoma	0.00041	0.00334	CcSEcCtD
Tenofovir—Nervous system disorder—Vincristine—sarcoma	0.000405	0.0033	CcSEcCtD
Tenofovir—Decreased appetite—Thiotepa—sarcoma	0.000405	0.0033	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Thiotepa—sarcoma	0.000402	0.00328	CcSEcCtD
Tenofovir—Decreased appetite—Dactinomycin—sarcoma	0.000402	0.00328	CcSEcCtD
Tenofovir—Fatigue—Thiotepa—sarcoma	0.000402	0.00327	CcSEcCtD
Tenofovir—Renal impairment—Epirubicin—sarcoma	0.000401	0.00327	CcSEcCtD
Tenofovir—ABCC2—lymph node—sarcoma	0.000401	0.00403	CbGeAlD
Tenofovir—Hyperhidrosis—Vincristine—sarcoma	0.0004	0.00325	CcSEcCtD
Tenofovir—Fatigue—Dactinomycin—sarcoma	0.000399	0.00325	CcSEcCtD
Tenofovir—Pain—Thiotepa—sarcoma	0.000399	0.00325	CcSEcCtD
Tenofovir—Back pain—Etoposide—sarcoma	0.000397	0.00323	CcSEcCtD
Tenofovir—Pain—Dactinomycin—sarcoma	0.000396	0.00322	CcSEcCtD
Tenofovir—Anorexia—Vincristine—sarcoma	0.000394	0.00321	CcSEcCtD
Tenofovir—Skin disorder—Mitoxantrone—sarcoma	0.000391	0.00318	CcSEcCtD
Tenofovir—Hyperhidrosis—Mitoxantrone—sarcoma	0.000389	0.00317	CcSEcCtD
Tenofovir—Anorexia—Mitoxantrone—sarcoma	0.000384	0.00313	CcSEcCtD
Tenofovir—Renal failure acute—Doxorubicin—sarcoma	0.000383	0.00312	CcSEcCtD
Tenofovir—Gastrointestinal pain—Thiotepa—sarcoma	0.000381	0.0031	CcSEcCtD
Tenofovir—Gastrointestinal pain—Dactinomycin—sarcoma	0.000378	0.00308	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Vincristine—sarcoma	0.000377	0.00307	CcSEcCtD
Tenofovir—Insomnia—Vincristine—sarcoma	0.000374	0.00304	CcSEcCtD
Tenofovir—Renal impairment—Doxorubicin—sarcoma	0.000371	0.00302	CcSEcCtD
Tenofovir—Body temperature increased—Thiotepa—sarcoma	0.000369	0.003	CcSEcCtD
Tenofovir—Abdominal pain—Thiotepa—sarcoma	0.000369	0.003	CcSEcCtD
Tenofovir—CYP1A2—liver—sarcoma	0.000367	0.00369	CbGeAlD
Tenofovir—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000367	0.00299	CcSEcCtD
Tenofovir—Abdominal pain—Dactinomycin—sarcoma	0.000366	0.00298	CcSEcCtD
Tenofovir—Body temperature increased—Dactinomycin—sarcoma	0.000366	0.00298	CcSEcCtD
Tenofovir—Decreased appetite—Vincristine—sarcoma	0.000359	0.00293	CcSEcCtD
Tenofovir—Dyspnoea—Mitoxantrone—sarcoma	0.000359	0.00292	CcSEcCtD
Tenofovir—Blood creatinine increased—Epirubicin—sarcoma	0.000358	0.00291	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Vincristine—sarcoma	0.000357	0.00291	CcSEcCtD
Tenofovir—Fatigue—Vincristine—sarcoma	0.000356	0.0029	CcSEcCtD
Tenofovir—Dyspepsia—Mitoxantrone—sarcoma	0.000354	0.00289	CcSEcCtD
Tenofovir—Pain—Vincristine—sarcoma	0.000353	0.00288	CcSEcCtD
Tenofovir—Decreased appetite—Mitoxantrone—sarcoma	0.00035	0.00285	CcSEcCtD
Tenofovir—Chest pain—Etoposide—sarcoma	0.000349	0.00284	CcSEcCtD
Tenofovir—Hypokalaemia—Epirubicin—sarcoma	0.000348	0.00283	CcSEcCtD
Tenofovir—Fatigue—Mitoxantrone—sarcoma	0.000347	0.00283	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000347	0.00283	CcSEcCtD
Tenofovir—Pain—Mitoxantrone—sarcoma	0.000344	0.0028	CcSEcCtD
Tenofovir—Hypersensitivity—Thiotepa—sarcoma	0.000343	0.0028	CcSEcCtD
Tenofovir—Nasopharyngitis—Epirubicin—sarcoma	0.000342	0.00278	CcSEcCtD
Tenofovir—Hypersensitivity—Dactinomycin—sarcoma	0.000341	0.00278	CcSEcCtD
Tenofovir—Gastrointestinal pain—Vincristine—sarcoma	0.000338	0.00275	CcSEcCtD
Tenofovir—Muscular weakness—Epirubicin—sarcoma	0.000337	0.00274	CcSEcCtD
Tenofovir—Asthenia—Thiotepa—sarcoma	0.000334	0.00272	CcSEcCtD
Tenofovir—Asthenia—Dactinomycin—sarcoma	0.000332	0.0027	CcSEcCtD
Tenofovir—Blood creatinine increased—Doxorubicin—sarcoma	0.000331	0.0027	CcSEcCtD
Tenofovir—Pruritus—Thiotepa—sarcoma	0.00033	0.00269	CcSEcCtD
Tenofovir—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000329	0.00268	CcSEcCtD
Tenofovir—Abdominal pain—Vincristine—sarcoma	0.000327	0.00266	CcSEcCtD
Tenofovir—Body temperature increased—Vincristine—sarcoma	0.000327	0.00266	CcSEcCtD
Tenofovir—Skin disorder—Etoposide—sarcoma	0.000325	0.00265	CcSEcCtD
Tenofovir—Hyperhidrosis—Etoposide—sarcoma	0.000324	0.00264	CcSEcCtD
Tenofovir—Pancreatitis—Epirubicin—sarcoma	0.000324	0.00264	CcSEcCtD
Tenofovir—Hypokalaemia—Doxorubicin—sarcoma	0.000322	0.00262	CcSEcCtD
Tenofovir—Anorexia—Etoposide—sarcoma	0.000319	0.0026	CcSEcCtD
Tenofovir—Diarrhoea—Thiotepa—sarcoma	0.000319	0.0026	CcSEcCtD
Tenofovir—Abdominal pain—Mitoxantrone—sarcoma	0.000318	0.00259	CcSEcCtD
Tenofovir—Body temperature increased—Mitoxantrone—sarcoma	0.000318	0.00259	CcSEcCtD
Tenofovir—Diarrhoea—Dactinomycin—sarcoma	0.000317	0.00258	CcSEcCtD
Tenofovir—Nasopharyngitis—Doxorubicin—sarcoma	0.000316	0.00257	CcSEcCtD
Tenofovir—Muscular weakness—Doxorubicin—sarcoma	0.000312	0.00254	CcSEcCtD
Tenofovir—Dizziness—Thiotepa—sarcoma	0.000308	0.00251	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Epirubicin—sarcoma	0.000307	0.0025	CcSEcCtD
Tenofovir—Hypersensitivity—Vincristine—sarcoma	0.000305	0.00248	CcSEcCtD
Tenofovir—Pancreatitis—Doxorubicin—sarcoma	0.000299	0.00244	CcSEcCtD
Tenofovir—Weight decreased—Epirubicin—sarcoma	0.000299	0.00243	CcSEcCtD
Tenofovir—Dyspnoea—Etoposide—sarcoma	0.000299	0.00243	CcSEcCtD
Tenofovir—Hyperglycaemia—Epirubicin—sarcoma	0.000298	0.00243	CcSEcCtD
Tenofovir—Hypersensitivity—Mitoxantrone—sarcoma	0.000297	0.00242	CcSEcCtD
Tenofovir—Asthenia—Vincristine—sarcoma	0.000297	0.00242	CcSEcCtD
Tenofovir—Vomiting—Thiotepa—sarcoma	0.000296	0.00241	CcSEcCtD
Tenofovir—Pneumonia—Epirubicin—sarcoma	0.000296	0.00241	CcSEcCtD
Tenofovir—Infestation—Epirubicin—sarcoma	0.000294	0.0024	CcSEcCtD
Tenofovir—Infestation NOS—Epirubicin—sarcoma	0.000294	0.0024	CcSEcCtD
Tenofovir—Vomiting—Dactinomycin—sarcoma	0.000294	0.0024	CcSEcCtD
Tenofovir—Rash—Thiotepa—sarcoma	0.000294	0.00239	CcSEcCtD
Tenofovir—Dermatitis—Thiotepa—sarcoma	0.000294	0.00239	CcSEcCtD
Tenofovir—Headache—Thiotepa—sarcoma	0.000292	0.00238	CcSEcCtD
Tenofovir—Rash—Dactinomycin—sarcoma	0.000292	0.00238	CcSEcCtD
Tenofovir—Decreased appetite—Etoposide—sarcoma	0.000291	0.00237	CcSEcCtD
Tenofovir—Renal failure—Epirubicin—sarcoma	0.000289	0.00236	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Etoposide—sarcoma	0.000289	0.00235	CcSEcCtD
Tenofovir—Asthenia—Mitoxantrone—sarcoma	0.000289	0.00235	CcSEcCtD
Tenofovir—Fatigue—Etoposide—sarcoma	0.000289	0.00235	CcSEcCtD
Tenofovir—Neuropathy peripheral—Epirubicin—sarcoma	0.000288	0.00235	CcSEcCtD
Tenofovir—Pain—Etoposide—sarcoma	0.000286	0.00233	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000284	0.00231	CcSEcCtD
Tenofovir—Diarrhoea—Vincristine—sarcoma	0.000283	0.0023	CcSEcCtD
Tenofovir—Sweating—Epirubicin—sarcoma	0.000282	0.0023	CcSEcCtD
Tenofovir—Haematuria—Epirubicin—sarcoma	0.000281	0.00229	CcSEcCtD
Tenofovir—Hepatobiliary disease—Epirubicin—sarcoma	0.000278	0.00227	CcSEcCtD
Tenofovir—Nausea—Thiotepa—sarcoma	0.000277	0.00226	CcSEcCtD
Tenofovir—Weight decreased—Doxorubicin—sarcoma	0.000276	0.00225	CcSEcCtD
Tenofovir—Sinusitis—Epirubicin—sarcoma	0.000276	0.00225	CcSEcCtD
Tenofovir—Hyperglycaemia—Doxorubicin—sarcoma	0.000276	0.00224	CcSEcCtD
Tenofovir—Diarrhoea—Mitoxantrone—sarcoma	0.000275	0.00224	CcSEcCtD
Tenofovir—Nausea—Dactinomycin—sarcoma	0.000275	0.00224	CcSEcCtD
Tenofovir—Pneumonia—Doxorubicin—sarcoma	0.000274	0.00223	CcSEcCtD
Tenofovir—Gastrointestinal pain—Etoposide—sarcoma	0.000274	0.00223	CcSEcCtD
Tenofovir—Dizziness—Vincristine—sarcoma	0.000273	0.00223	CcSEcCtD
Tenofovir—Infestation NOS—Doxorubicin—sarcoma	0.000272	0.00222	CcSEcCtD
Tenofovir—Infestation—Doxorubicin—sarcoma	0.000272	0.00222	CcSEcCtD
Tenofovir—Renal failure—Doxorubicin—sarcoma	0.000268	0.00218	CcSEcCtD
Tenofovir—Neuropathy peripheral—Doxorubicin—sarcoma	0.000267	0.00217	CcSEcCtD
Tenofovir—Abdominal pain—Etoposide—sarcoma	0.000265	0.00216	CcSEcCtD
Tenofovir—Body temperature increased—Etoposide—sarcoma	0.000265	0.00216	CcSEcCtD
Tenofovir—Hepatitis—Epirubicin—sarcoma	0.000264	0.00215	CcSEcCtD
Tenofovir—Vomiting—Vincristine—sarcoma	0.000263	0.00214	CcSEcCtD
Tenofovir—Sweating—Doxorubicin—sarcoma	0.000261	0.00213	CcSEcCtD
Tenofovir—Urinary tract disorder—Epirubicin—sarcoma	0.000261	0.00212	CcSEcCtD
Tenofovir—Rash—Vincristine—sarcoma	0.000261	0.00212	CcSEcCtD
Tenofovir—Dermatitis—Vincristine—sarcoma	0.00026	0.00212	CcSEcCtD
Tenofovir—Haematuria—Doxorubicin—sarcoma	0.00026	0.00211	CcSEcCtD
Tenofovir—Connective tissue disorder—Epirubicin—sarcoma	0.00026	0.00211	CcSEcCtD
Tenofovir—Urethral disorder—Epirubicin—sarcoma	0.000259	0.00211	CcSEcCtD
Tenofovir—Headache—Vincristine—sarcoma	0.000259	0.00211	CcSEcCtD
Tenofovir—Hepatobiliary disease—Doxorubicin—sarcoma	0.000258	0.0021	CcSEcCtD
Tenofovir—Vomiting—Mitoxantrone—sarcoma	0.000256	0.00208	CcSEcCtD
Tenofovir—Sinusitis—Doxorubicin—sarcoma	0.000255	0.00208	CcSEcCtD
Tenofovir—Rash—Mitoxantrone—sarcoma	0.000254	0.00207	CcSEcCtD
Tenofovir—Dermatitis—Mitoxantrone—sarcoma	0.000254	0.00207	CcSEcCtD
Tenofovir—Headache—Mitoxantrone—sarcoma	0.000252	0.00205	CcSEcCtD
Tenofovir—Hypersensitivity—Etoposide—sarcoma	0.000247	0.00201	CcSEcCtD
Tenofovir—Nausea—Vincristine—sarcoma	0.000246	0.002	CcSEcCtD
Tenofovir—Hepatitis—Doxorubicin—sarcoma	0.000244	0.00199	CcSEcCtD
Tenofovir—Urinary tract disorder—Doxorubicin—sarcoma	0.000241	0.00197	CcSEcCtD
Tenofovir—Asthenia—Etoposide—sarcoma	0.00024	0.00196	CcSEcCtD
Tenofovir—Connective tissue disorder—Doxorubicin—sarcoma	0.00024	0.00196	CcSEcCtD
Tenofovir—Urethral disorder—Doxorubicin—sarcoma	0.00024	0.00195	CcSEcCtD
Tenofovir—Nausea—Mitoxantrone—sarcoma	0.000239	0.00195	CcSEcCtD
Tenofovir—Immune system disorder—Epirubicin—sarcoma	0.000239	0.00194	CcSEcCtD
Tenofovir—Mediastinal disorder—Epirubicin—sarcoma	0.000238	0.00194	CcSEcCtD
Tenofovir—Pruritus—Etoposide—sarcoma	0.000237	0.00193	CcSEcCtD
Tenofovir—Mental disorder—Epirubicin—sarcoma	0.000231	0.00189	CcSEcCtD
Tenofovir—Malnutrition—Epirubicin—sarcoma	0.00023	0.00187	CcSEcCtD
Tenofovir—Diarrhoea—Etoposide—sarcoma	0.000229	0.00187	CcSEcCtD
Tenofovir—Flatulence—Epirubicin—sarcoma	0.000227	0.00185	CcSEcCtD
Tenofovir—Back pain—Epirubicin—sarcoma	0.000222	0.00181	CcSEcCtD
Tenofovir—Dizziness—Etoposide—sarcoma	0.000221	0.0018	CcSEcCtD
Tenofovir—Immune system disorder—Doxorubicin—sarcoma	0.000221	0.0018	CcSEcCtD
Tenofovir—Mediastinal disorder—Doxorubicin—sarcoma	0.00022	0.00179	CcSEcCtD
Tenofovir—Mental disorder—Doxorubicin—sarcoma	0.000214	0.00174	CcSEcCtD
Tenofovir—Vomiting—Etoposide—sarcoma	0.000213	0.00173	CcSEcCtD
Tenofovir—Malnutrition—Doxorubicin—sarcoma	0.000213	0.00173	CcSEcCtD
Tenofovir—Rash—Etoposide—sarcoma	0.000211	0.00172	CcSEcCtD
Tenofovir—Dermatitis—Etoposide—sarcoma	0.000211	0.00172	CcSEcCtD
Tenofovir—Headache—Etoposide—sarcoma	0.00021	0.00171	CcSEcCtD
Tenofovir—Flatulence—Doxorubicin—sarcoma	0.00021	0.00171	CcSEcCtD
Tenofovir—Back pain—Doxorubicin—sarcoma	0.000206	0.00168	CcSEcCtD
Tenofovir—Nausea—Etoposide—sarcoma	0.000199	0.00162	CcSEcCtD
Tenofovir—Arthralgia—Epirubicin—sarcoma	0.000196	0.00159	CcSEcCtD
Tenofovir—Myalgia—Epirubicin—sarcoma	0.000196	0.00159	CcSEcCtD
Tenofovir—Chest pain—Epirubicin—sarcoma	0.000196	0.00159	CcSEcCtD
Tenofovir—Anxiety—Epirubicin—sarcoma	0.000195	0.00159	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000194	0.00158	CcSEcCtD
Tenofovir—Nervous system disorder—Epirubicin—sarcoma	0.000184	0.0015	CcSEcCtD
Tenofovir—Skin disorder—Epirubicin—sarcoma	0.000182	0.00148	CcSEcCtD
Tenofovir—Hyperhidrosis—Epirubicin—sarcoma	0.000181	0.00148	CcSEcCtD
Tenofovir—Myalgia—Doxorubicin—sarcoma	0.000181	0.00148	CcSEcCtD
Tenofovir—Chest pain—Doxorubicin—sarcoma	0.000181	0.00148	CcSEcCtD
Tenofovir—Arthralgia—Doxorubicin—sarcoma	0.000181	0.00148	CcSEcCtD
Tenofovir—Anxiety—Doxorubicin—sarcoma	0.000181	0.00147	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00018	0.00147	CcSEcCtD
Tenofovir—Anorexia—Epirubicin—sarcoma	0.000179	0.00146	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000171	0.00139	CcSEcCtD
Tenofovir—Nervous system disorder—Doxorubicin—sarcoma	0.00017	0.00139	CcSEcCtD
Tenofovir—Insomnia—Epirubicin—sarcoma	0.00017	0.00138	CcSEcCtD
Tenofovir—Skin disorder—Doxorubicin—sarcoma	0.000169	0.00137	CcSEcCtD
Tenofovir—Hyperhidrosis—Doxorubicin—sarcoma	0.000168	0.00137	CcSEcCtD
Tenofovir—Dyspnoea—Epirubicin—sarcoma	0.000167	0.00136	CcSEcCtD
Tenofovir—Anorexia—Doxorubicin—sarcoma	0.000166	0.00135	CcSEcCtD
Tenofovir—Dyspepsia—Epirubicin—sarcoma	0.000165	0.00135	CcSEcCtD
Tenofovir—Decreased appetite—Epirubicin—sarcoma	0.000163	0.00133	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Epirubicin—sarcoma	0.000162	0.00132	CcSEcCtD
Tenofovir—Fatigue—Epirubicin—sarcoma	0.000162	0.00132	CcSEcCtD
Tenofovir—Pain—Epirubicin—sarcoma	0.000161	0.00131	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000158	0.00129	CcSEcCtD
Tenofovir—Insomnia—Doxorubicin—sarcoma	0.000157	0.00128	CcSEcCtD
Tenofovir—Dyspnoea—Doxorubicin—sarcoma	0.000155	0.00126	CcSEcCtD
Tenofovir—Gastrointestinal pain—Epirubicin—sarcoma	0.000153	0.00125	CcSEcCtD
Tenofovir—Dyspepsia—Doxorubicin—sarcoma	0.000153	0.00125	CcSEcCtD
Tenofovir—Decreased appetite—Doxorubicin—sarcoma	0.000151	0.00123	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00015	0.00122	CcSEcCtD
Tenofovir—Fatigue—Doxorubicin—sarcoma	0.00015	0.00122	CcSEcCtD
Tenofovir—Pain—Doxorubicin—sarcoma	0.000149	0.00121	CcSEcCtD
Tenofovir—Abdominal pain—Epirubicin—sarcoma	0.000148	0.00121	CcSEcCtD
Tenofovir—Body temperature increased—Epirubicin—sarcoma	0.000148	0.00121	CcSEcCtD
Tenofovir—Gastrointestinal pain—Doxorubicin—sarcoma	0.000142	0.00116	CcSEcCtD
Tenofovir—Hypersensitivity—Epirubicin—sarcoma	0.000138	0.00113	CcSEcCtD
Tenofovir—Abdominal pain—Doxorubicin—sarcoma	0.000137	0.00112	CcSEcCtD
Tenofovir—Body temperature increased—Doxorubicin—sarcoma	0.000137	0.00112	CcSEcCtD
Tenofovir—Asthenia—Epirubicin—sarcoma	0.000135	0.0011	CcSEcCtD
Tenofovir—Pruritus—Epirubicin—sarcoma	0.000133	0.00108	CcSEcCtD
Tenofovir—Diarrhoea—Epirubicin—sarcoma	0.000128	0.00105	CcSEcCtD
Tenofovir—Hypersensitivity—Doxorubicin—sarcoma	0.000128	0.00104	CcSEcCtD
Tenofovir—Asthenia—Doxorubicin—sarcoma	0.000125	0.00101	CcSEcCtD
Tenofovir—Dizziness—Epirubicin—sarcoma	0.000124	0.00101	CcSEcCtD
Tenofovir—Pruritus—Doxorubicin—sarcoma	0.000123	0.001	CcSEcCtD
Tenofovir—Vomiting—Epirubicin—sarcoma	0.000119	0.000972	CcSEcCtD
Tenofovir—Diarrhoea—Doxorubicin—sarcoma	0.000119	0.000968	CcSEcCtD
Tenofovir—Rash—Epirubicin—sarcoma	0.000118	0.000964	CcSEcCtD
Tenofovir—Dermatitis—Epirubicin—sarcoma	0.000118	0.000963	CcSEcCtD
Tenofovir—Headache—Epirubicin—sarcoma	0.000118	0.000958	CcSEcCtD
Tenofovir—Dizziness—Doxorubicin—sarcoma	0.000115	0.000935	CcSEcCtD
Tenofovir—Nausea—Epirubicin—sarcoma	0.000111	0.000908	CcSEcCtD
Tenofovir—Vomiting—Doxorubicin—sarcoma	0.00011	0.000899	CcSEcCtD
Tenofovir—Rash—Doxorubicin—sarcoma	0.00011	0.000892	CcSEcCtD
Tenofovir—Dermatitis—Doxorubicin—sarcoma	0.000109	0.000891	CcSEcCtD
Tenofovir—Headache—Doxorubicin—sarcoma	0.000109	0.000886	CcSEcCtD
Tenofovir—Nausea—Doxorubicin—sarcoma	0.000103	0.00084	CcSEcCtD
